Sarah is a Clinical Immunologist/Immunopathologist and Scientia Senior Lecturer. She graduated from a BSc(HonsI)/BA (English) prior to a combined MBBS(Hons)/PhD program. Sarah completed specialist medical training in Clinical Immunology and Immunopathology at St Vincent's, Royal Prince Alfred, Concord, Liverpool and Campbelltown Hospitals and gained dual fellowships of the Royal Australasian College of Physicians and Royal College of Pathologists Australasia in 2017. From 2018-2019 Sarah undertook postdoctoral studies at the University of Oxford investigating autoimmune toxicities of immune checkpoint inhibitors in Professor Paul Klenerman's laboratory.
Sarah's broad research area is human translational Immunology. Her particular interests include the role of T cells in the control of cancers and sepsis as well as COVID-19 in immunocompromised people.
Broad Research Areas:
Immunology, Infectious Diseases, Cancer Immunology, Immune Checkpoint Inhibitors, Mucosal Immunology, Sepsis
BA, BSc(Hons I), MBBS(Hons), PhD, FRACP, FRCPA